Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

for
ADHD
Location: Everett WA, Portland OR, Walnut Creek CA, Provo UT,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 6 - 11

Code: NCT07717879

Phase 3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Post Falls ID, Coeur d'Alene ID, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Tacoma WA, Puyallup WA, Redmond WA, Portland OR,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

for
EGFRI Induced Acneiform Lesions
Location: Tacoma WA, Glendale CA, Santa Monica CA, Shreveport LA,
Sponsor: Lutris Pharma Ltd.

Sex: All

Age: 18+

Code: NCT04759664

Phase 2, Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Tacoma WA, Seattle WA, Eugene OR, Aurora CO, Phoenix AZ,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Tacoma WA, San Francisco CA, Rochester MN, Dallas TX,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase 1, Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

for
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype,
Location: Tacoma WA, Glendale CA, Beverly Hills CA,
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06047379

Phase 1, Phase 2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Tacoma WA, Seattle WA, Eugene OR, Edmonton,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Tacoma WA, Federal Way WA, Puyallup WA, Gig Harbor WA,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase 3, Recruiting

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for
Prostate Cancer,
Location: Tacoma WA, Santa Rosa CA, Anaheim CA, Albuquerque NM,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT04729114

Phase 1, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Tacoma WA, Seattle WA, Eugene OR, Salt Lake City UT,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Tacoma WA, Portland OR, Vancouver, Calgary, Edmonton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Tacoma WA, Portland OR, Stockton CA, Oxnard CA,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

for
Non Small Cell Lung Carcinoma, c-MET
Location: Tacoma WA, Olympia WA, Salt Lake City UT, Oxnard CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06772623

Phase 1, Phase 2, Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer, c-MET
Location: Tacoma WA, Spokane WA, Reno NV, Ogden UT, Oxnard CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase 2, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Tacoma WA, Salt Lake City UT, Clovis CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase 3, Recruiting

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Tacoma WA, Reno NV, Los Angeles CA, Lubbock TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07609940

Phase 4, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Tacoma WA, Olympia WA, Yakima WA, Salem OR, Eugene OR,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Tacoma WA, Eugene OR, Calgary, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma (HCC)
Location: Tacoma WA, Olympia WA, Glendale CA, Houston TX,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18 - 65

Code: NCT07176650

Phase 1, Recruiting